Monday 12/29 Insider Buying Report: MNPR
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money. Today we look at a recent insider purchase of note.
At Monopar Therapeutics, a filing with the SEC revealed that on Friday, Chief Financial Officer Quan Anh Vu purchased 1,500 shares of MNPR, for a cost of $69.95 each, for a total investment of $104,925. Monopar Therapeutics is trading off about 1.1% on the day Monday. This purchase marks the first one filed by Vu in the past twelve months.
VIDEO: Monday 12/29 Insider Buying Report: MNPR
BNK Invest Inc. provides investment services and information. BNK Invest owns and operates a market news family of websites including DividendChannel, ETFChannel, StockOptionsChannel, and others, which make up an investor community featuring stock message boards, ratings, research, and strategies. BNK Invest caters to investing firms and individual investors internationally.